Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 1
1983 2
1986 2
1987 2
1988 2
1989 1
1991 2
1992 2
1993 2
1994 6
1995 2
1996 3
1997 1
1998 1
2000 1
2002 2
2003 2
2004 1
2005 1
2006 3
2007 5
2008 6
2009 8
2010 9
2011 11
2012 7
2013 10
2014 13
2015 18
2016 12
2017 14
2018 11
2019 10
2020 13
2021 22
2022 25
2023 23
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

231 results

Results by year

Filters applied: . Clear all
Page 1
Tapinarof for the treatment of psoriasis.
Nogueira S, Rodrigues MA, Vender R, Torres T. Nogueira S, et al. Among authors: vender r. Dermatol Ther. 2022 Dec;35(12):e15931. doi: 10.1111/dth.15931. Epub 2022 Oct 21. Dermatol Ther. 2022. PMID: 36226669 Free PMC article. Review.
Leadership: an overview.
Vender RJ. Vender RJ. Am J Gastroenterol. 2015 Mar;110(3):362-7. doi: 10.1038/ajg.2014.199. Epub 2014 Jul 22. Am J Gastroenterol. 2015. PMID: 25047400 Review.
Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations.
Flume PA, Mogayzel PJ Jr, Robinson KA, Goss CH, Rosenblatt RL, Kuhn RJ, Marshall BC; Clinical Practice Guidelines for Pulmonary Therapies Committee. Flume PA, et al. Am J Respir Crit Care Med. 2009 Nov 1;180(9):802-8. doi: 10.1164/rccm.200812-1845PP. Epub 2009 Sep 3. Am J Respir Crit Care Med. 2009. PMID: 19729669 Review.
Secukinumab in plaque psoriasis--results of two phase 3 trials.
Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B, Rivas E, Tsai TF, Wasel N, Tyring S, Salko T, Hampele I, Notter M, Karpov A, Helou S, Papavassilis C; ERASURE Study Group; FIXTURE Study Group. Langley RG, et al. N Engl J Med. 2014 Jul 24;371(4):326-38. doi: 10.1056/NEJMoa1314258. Epub 2014 Jul 9. N Engl J Med. 2014. PMID: 25007392 Free article. Clinical Trial.
Molecular source attribution.
Chao E, Chato C, Vender R, Olabode AS, Ferreira RC, Poon AFY. Chao E, et al. Among authors: vender r. PLoS Comput Biol. 2022 Nov 17;18(11):e1010649. doi: 10.1371/journal.pcbi.1010649. eCollection 2022 Nov. PLoS Comput Biol. 2022. PMID: 36395093 Free PMC article. No abstract available.
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.
Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, Ratjen F, Rowe SM, Waltz D, Boyle MP; TRAFFIC Study Group; TRANSPORT Study Group. Wainwright CE, et al. N Engl J Med. 2015 Jul 16;373(3):220-31. doi: 10.1056/NEJMoa1409547. Epub 2015 May 17. N Engl J Med. 2015. PMID: 25981758 Free PMC article. Clinical Trial.
Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV study (IMMpulse).
Stein Gold LF, Bagel J, Tyring SK, Hong HC, Pavlovsky L, Vender R, Pinter A, Reich A, Drogaris L, Wu T, Patel M, Soliman AM, Photowala H, Stakias V, Richter S, Papp KA. Stein Gold LF, et al. Among authors: vender r. Br J Dermatol. 2023 Oct 25;189(5):540-552. doi: 10.1093/bjd/ljad252. Br J Dermatol. 2023. PMID: 37488811 Clinical Trial.
231 results